ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On June 30, 2020, Avid Bioservices, Inc. (the "Company") issued a press release
to report the Company's financial results for the fourth quarter and fiscal year
ended April 30, 2020. A copy of the press release is attached to this Current
Report on Form 8-K as Exhibit 99.1. No additional information is included in
this Current Report on Form 8-K.
The information included in this Current Report on Form 8-K, including the
exhibit hereto, shall not be deemed "filed" for purposes of, nor shall it be
deemed incorporated by reference in, any filing under the Securities Act of 1933
or the Securities Exchange Act of 1934, except as expressly set forth by
specific reference in such a filing.
ITEM 7.01 REGULATION FD DISCLOSURE
On June 30, 2020, at 4:30 p.m. EDT/1:30 p.m. PDT, the Company will host a
conference call to discuss its fourth quarter and fiscal year ended April 30,
2020 financial results. The webcast of the conference call will be archived on
the Company's website for approximately 30 days.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits. The following material is filed as an exhibit to this Current
Report on Form 8-K:
99.1 Press Release issued June 30, 2020 .
© Edgar Online, source Glimpses